The β3-Adrenoceptor Agonist GW427353 (Solabegron) Decreases Excitability of Human Enteric Neurons via Release of Somatostatin
To access this article, please choose from the options below
Conflicts of interest K.L. is an employee of GlaxoSmithKline, UK. S.C. and O.I.K. were employees of GSK at the time of the experiments. The remaining authors have no conflicts to disclose.
Funding This study has been in part supported by a research grant from GlaxoSmithKline.
PII: S0016-5085(09)01696-5
doi:10.1053/j.gastro.2009.09.046
© 2010 AGA Institute. Published by Elsevier Inc. All rights reserved.

